Thumbnails similares a Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk

20 vecinos (thumb_512) · 120 views · HCPLive · Estados Unidos


★	Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk	HCPLive @hcplivenews	120	Estados Unidos
20	Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome	HCPLive @hcplivenews	2.0K	Estados Unidos	71
4	Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment	HCPLive @hcplivenews	374	Estados Unidos	74
19	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	71
17	Aortic Dissection: A Fatal Condition With an Underrepresented Genetic Risk	HCPLive @hcplivenews	155	Estados Unidos	71
15	AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines	HCPLive @hcplivenews	129	Estados Unidos	71
8	Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes \| ATS 2026	HCPLive @hcplivenews	117	Estados Unidos	73
18	How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD	HCPLive @hcplivenews	109	Estados Unidos	71
3	VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes	HCPLive @hcplivenews	96	Estados Unidos	75
10	MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins	HCPLive @hcplivenews	86	Estados Unidos	72
14	How a Nephrologist Diagnoses and Manages Chronic Kidney Disease	HCPLive @hcplivenews	70	Estados Unidos	72
12	Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD	HCPLive @hcplivenews	69	Estados Unidos	72
9	Closing Gaps in IgA Nephropathy Diagnosis and Treatment, With Brad Rovin, MD	HCPLive @hcplivenews	60	Estados Unidos	73
16	Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy	HCPLive @hcplivenews	55	Estados Unidos	71
1	FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines	HCPLive @hcplivenews	33	Estados Unidos	78
7	Diagnosing Non-IgE Food Hypersensitivity \| Brian Lacy, MD, PhD \| EAC 2026	HCPLive @hcplivenews	31	Estados Unidos	73
2	Why Quality of Life Can't Take a Back Seat in ISM: Thanai Pongdee, MD, on New PIONEER Data	HCPLive @hcplivenews	27	Estados Unidos	75
5	Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD	HCPLive @hcplivenews	21	Estados Unidos	74
6	Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP	HCPLive @hcplivenews	17	Estados Unidos	74
13	How Should Clinicians Address the Link Between Atopic Dermatitis and Allergy? With Jay Lieberman, MD	HCPLive @hcplivenews	13	Estados Unidos	72
11	What's Next for Peanut Allergy Microneedle Immunotherapy, With Brian Vickery, MD	HCPLive @hcplivenews	12	Estados Unidos	72